ClinVar Miner

Submissions for variant NM_001130987.2(DYSF):c.5410G>A (p.Val1804Met)

gnomAD frequency: 0.00001  dbSNP: rs773089790
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001325082 SCV001516059 uncertain significance Qualitative or quantitative defects of dysferlin 2022-10-13 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1765 of the DYSF protein (p.Val1765Met). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. ClinVar contains an entry for this variant (Variation ID: 1024849). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DYSF protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002546124 SCV003626090 uncertain significance Inborn genetic diseases 2022-06-29 criteria provided, single submitter clinical testing The c.5293G>A (p.V1765M) alteration is located in exon 47 (coding exon 47) of the DYSF gene. This alteration results from a G to A substitution at nucleotide position 5293, causing the valine (V) at amino acid position 1765 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV001830998 SCV002080321 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2B 2021-06-29 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.